| Voluma Filler Agent For The Treatment of HIV-associated Facial Lipoatrophy (NCT02342223) | Jared Jagdeo, MD, MS | 2015-02-01 |
| Simvastatin With Topotecan and Cyclophosphamide in Relapsed and/or Refractory Pediatric Solid and CNS Tumors (NCT02390843) | Emory University | 2015-02-01 |
| Food Effect Study of Febuxostat XR in Healthy Participants (NCT02374164) | Takeda | 2015-02-01 |
| Ibuprofen (MOMENT ACT ANALGESIC Granules) Pharmacokinetic Study (NCT02482155) | Aziende Chimiche Riunite Angelini Francesco S.p.A | 2015-02-01 |
| A Study of BBI608 Administrated With Sorafenib in Adult Patients With Advanced Hepatocellular Carcinoma (NCT02358395) | Sumitomo Pharma Co., Ltd. | 2015-02-01 |
| To Evaluate the Bioavailability of a Single Oral Dose of the Acetylsalicylic Acid Containing Dry Powder 500 mg in Comparison to the Bioavailability of a Single Oral Dose of Aspirin Tablets and Aspirin Effervescent Tablets in Healthy Adults. (NCT02394093) | Bayer | 2015-02-01 |
| A Study of LY2801653 in Healthy Participants Who Are Not Able to Have Children (NCT02370485) | Eli Lilly and Company | 2015-02-01 |
| Motor Cortex Stimulation for the Treatment of Chronic Facial, Upper Extremity, and Throat Pain. (NCT02321566) | Johns Hopkins University | 2015-02-01 |
| Study of Safety, Tolerability and Pharmacokinetics of NRX-1074 in Normal Healthy Volunteers (NCT02366364) | Naurex, Inc, an affiliate of Allergan plc | 2015-02-01 |
| Evaluation of the Safety and Potential Therapeutic Effects of Cordstem-ST in Patients With Cerebral Infarction (NCT02378974) | CHABiotech CO., Ltd | 2015-02-01 |
| Effect of Bronchial Thermoplasty on Moderate Bronchial Asthma in China (NCT02965807) | Guangzhou Institute of Respiratory Disease | 2015-02-01 |
| Drug-Drug Interaction Study Between TAK-272 and Itraconazole, Digoxin or Midazolam (NCT02370615) | Takeda | 2015-02-01 |
| A Randomized Double Blinded Study to Examine the Use of N-acetyl Cysteine for the Prevention and Treatment of HAAF in Patients With Type 1 Diabetes (NCT02206152) | University of Minnesota | 2015-02-01 |
| BYL719 and Nab-Paclitaxel in Locally Recurrent or Metastatic HER-2 Negative Breast Cancer (NCT02379247) | Priyanka Sharma | 2015-02-01 |
| Effect Aerobic Training on Women With Breast Cancer After Chemotherapy (NCT02876627) | University of Isfahan | 2015-02-01 |
| Rosuvastatin Interethnic PK Study (NCT02215174) | University of California, San Francisco | 2015-02-01 |
| Comparison of the Pharmacokinetic and Pharmacodynamic Biosimilarity of CHS-1701 (Coherus Pegfilgrastim) With Neulasta® (Pegfilgrastim) (NCT02385851) | Coherus Oncology, Inc. | 2015-02-01 |
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Food-Effect of KQ-791 (NCT02370043) | Kaneq Bioscience Limited | 2015-02-01 |
| Dental Implant Placement in Adjunction With Autologous Alveolar Bone-Marrow Derived Mesenchymal Stem Cells (aBM-MSCs) (NCT03070275) | Aristotle University Of Thessaloniki | 2015-02-01 |
| PK/PD of EA-230 During Endotoxemia (NCT02629874) | Radboud University Medical Center | 2015-02-01 |
| Tolerability, Safety and Pharmacokinetic Study Of Methosulide in Healthy Adult Subjects (NCT02374684) | Hubei Biological Medicine Industrial Technology Institute Co., Ltd. | 2015-02-01 |
| A Phase 1, Single Dose Study to Evaluate the Safety and Pharmacokinetics of MEDI0382 in Healthy Volunteers (NCT02394314) | MedImmune LLC | 2015-02-01 |
| A Gene Transfer Therapy Study to Evaluate the Safety of SRP-9004 (Patidistrogene Bexoparvovec) in Participants With Limb-Girdle Muscular Dystrophy, Type 2D (LGMD2D) (NCT01976091) | Sarepta Therapeutics, Inc. | 2015-02-01 |
| Pharmacokinetic Study of the Dapivirine Vaginal Ring in Lactating Women (NCT02808949) | International Partnership for Microbicides, Inc. | 2015-02-01 |
| Phase 1 Study of MGD010 in Healthy Subjects (NCT02376036) | MacroGenics | 2015-02-01 |
| Safety and PK Trial With Injectable ZX003 (Risperidone-SABER®) Compared to Risperdal® Consta® in Stable Schizophrenia (NCT02411526) | Zogenix, Inc. | 2015-02-01 |
| The Study of Rest Tremor Suppression by Using Electrical Muscle Stimulation (NCT02370108) | Chulalongkorn University | 2015-02-01 |
| Most Closely Matched 3rd Party Rapidly Generated LMP, BARF1 And EBNA1 Specific CTL, EBV-Positive Lymphoma (MABEL) (NCT02287311) | Baylor College of Medicine | 2015-02-01 |
| Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes (NCT02870244) | Loyola University | 2015-02-01 |
| A Pharmacokinetic, Safety and Tolerability Study in Healthy Adult Males (NCT02411500) | Trevena Inc. | 2015-02-01 |
| Phase 1b Study of CCX872-B in Patients With Pancreatic Adenocarcinoma (NCT02345408) | Amgen | 2015-02-01 |
| Safety and Pharmacokinetics of ODM-204 in Patients With Metastatic Castration-Resistant Prostate Cancer (NCT02344017) | Orion Corporation, Orion Pharma | 2015-02-01 |
| The ONE Study nTreg Trial (ONEnTreg13) (NCT02371434) | Prof. Dr. Petra Reinke | 2015-02-01 |
| Effects of Rifampin on the Pharmacokinetics of Ataluren (NCT02409004) | PTC Therapeutics | 2015-02-01 |
| A Study to Assess the Safety and Tolerability of Lucerastat in Subjects With Fabry Disease (NCT02930655) | Idorsia Pharmaceuticals Ltd. | 2015-02-01 |
| Cystoscopic Ablation Via RF Energy Clinical Trial (NCT02398578) | Amphora Medical, Inc. | 2015-02-01 |
| Exploratory Study of MT-1303 in Systemic Lupus Erythematosus Patients (NCT02307643) | Tanabe Pharma Corporation | 2015-02-01 |
| Human Autologous MSCs for the Treatment of Mid to Late Stage Knee OA (NCT02351011) | Jas Chahal | 2015-02-01 |
| Eculizumab Therapy for Subclinical Antibody-mediated Rejection in Kidney Transplantation (NCT02113891) | Assistance Publique - Hôpitaux de Paris | 2015-02-01 |
| Berry Intake - Effects on Systemic and Oral Inflammation (NCT02370966) | Kristianstad University | 2015-02-01 |
| Phase I Study PK Study With OXP005 and Naprosyn (NCT02351024) | Oxford Pharmascience Ltd | 2015-02-01 |
| A Study of Sofosbuvir From Heterosofir 400 mg F.C.T (Pharmed Healthcare, Egypt) & Sovaldi 400 mg F.C.T ( Gilead Sciences, Ireland) (NCT02491450) | Genuine Research Center, Egypt | 2015-02-01 |
| Study of Gemcitabine/Taxotere/Xeloda (GTX) in Combination With Cisplatin and Irinotecan in Subjects With Metastatic Pancreatic Cancer (NCT02324543) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2015-02-01 |
| The Efficacy of Denosumab in Active Crohn's Disease (NCT02321280) | University of Manitoba | 2015-02-01 |
| Effect of Nicotine on Brain Reward Pathways (NCT02346539) | Mclean Hospital | 2015-02-01 |
| An Open-Label, Phase 1b Study of Acalabrutinib With and Without Dexamethasone in Subjects With Multiple Myeloma (NCT02211014) | Acerta Pharma BV | 2015-02-01 |
| Dose-Escalation Study of SCD-101 in Sickle Cell Disease (NCT02380079) | Invenux, LLC | 2015-02-01 |
| Renal Allograft Tolerance Through Mixed Chimerism (Belatacept) (NCT02314403) | Massachusetts General Hospital | 2015-02-01 |
| Pharmacokinetics Study of CJ-30060 After Single Dose Administration in Health Male Volunteers (NCT03009474) | HK inno.N Corporation | 2015-02-01 |
| Metronomic Chemotherapy in Patients With Advanced Solid Tumor With Bone Metastasis and Advanced Pretreated Osteosarcoma (NCT02517918) | Institut Bergonié | 2015-02-01 |
| D-mannose for the Prevention of UTIs in Multiple Sclerosis (NCT02490046) | University College, London | 2015-02-01 |
| Reduction of the Speed of Eating as an Intervention in Obesity (NCT02381327) | Mando Group AB | 2015-02-01 |
| Effect of Vitamin D3 Supplementation in Treatment of Irritable Bowel Syndrome (NCT02579902) | Ahvaz Jundishapur University of Medical Sciences | 2015-02-01 |
| Contrast-Enhanced Ultrasound in Human Crohn's Disease (NCT02061163) | University of Michigan | 2015-02-01 |
| A Study of Nelfinavir Added to Cisplatin Chemotherapy Concurrent With Pelvic Radiation for Locally Advanced Cervical Cancer (II-IVA) (NCT02363829) | Abramson Cancer Center at Penn Medicine | 2015-02-01 |
| A Study of Ramucirumab Combination Therapy in Japanese Participants Who Have Advanced Stomach Cancer (NCT02359058) | Eli Lilly and Company | 2015-02-01 |
| The PK/PD, Efficacy, Safety and Tolerability Study of SHR3824 in Type 2 Diabetes Mellitus Patients (NCT02366351) | Jiangsu HengRui Medicine Co., Ltd. | 2015-02-01 |
| A Phase I Study of a Therapeutic Vaccine Candidate in Patients With Localized Breast Cancer at High-Risk of Relapse (NCT02364492) | Institut Pasteur | 2015-02-01 |
| TGF-beta Resistant Cytotoxic T-lymphocytes in Treatment of EBV-positive Nasopharyngeal Carcinoma / RESIST-NPC (NCT02065362) | Baylor College of Medicine | 2015-02-01 |
| Bioequivalence Study Between 400 mg LX4211 Tablets and 2 X 200 mg LX4211 Tablets (NCT02373046) | Lexicon Pharmaceuticals | 2015-02-01 |
| Safety and Tolerability of a Bioconjugate Vaccine Against Shigella Flexneri 2a (NCT02388009) | LimmaTech Biologics AG | 2015-02-01 |
| Mesenchymal Stem Cells Therapy for Treatment of Airway Remodeling in Mustard Patients (NCT02749448) | Dr. Mostafa Ghanei | 2015-02-01 |
| Phase I BKM120/Abraxane in Solid Tumors, Expansion Phase Recurrent Endometrial or Ovarian Cancer (NCT02117817) | Rutgers, The State University of New Jersey | 2015-02-01 |
| Use of Hyperpolarized 129Xe MR Lung Imaging in Adults for Calibration (NCT02316379) | Children's Hospital Medical Center, Cincinnati | 2015-02-01 |
| Dose Escalation Study of I-131-CLR1404 in Patients With Relapsed or Refractory Multiple Myeloma (NCT02278315) | Cellectar Biosciences, Inc. | 2015-02-01 |
| Absorption, Metabolism, Excretion, and the Determination of Absolute Bioavailability of Niraparib in Subjects With Cancer (NCT02476552) | Tesaro, Inc. | 2015-02-01 |
| Naproxen Sodium/ASA Platelet Study (NCT02229461) | Bayer | 2015-02-01 |
| SL-401 as Consolidation Therapy in Patients With Adverse Risk Acute Myeloid Leukemia in First Complete Remission (NCT02270463) | Stemline Therapeutics, Inc. | 2015-02-01 |
| Velcade and Lenalidomide in Patients With Relapsed AML and MDS After Allogeneic Stem Cell Transplantation (NCT02312102) | Massachusetts General Hospital | 2015-02-01 |
| Procaspase Activating Compound-1 (PAC-1) in the Treatment of Advanced Malignancies - Component 1 (NCT02355535) | Vanquish Oncology, Inc. | 2015-02-01 |
| Relative Bioavailability Study in Healthy Subjects Comparing 2 Dry Powder Oral Suspensions of Rivaroxaban Under Fasting and 20 mg of an Oral Suspension of Rivaroxaban Under Fed Conditions to 10 mg of an Immediate Release Tablet Under Fasting Conditions (NCT02367027) | Bayer | 2015-02-01 |
| The PK/PD, Efficacy, Safety and Tolerability Study of SHR3824 in Combination With Metformin in Type 2 Diabetes Mellitus Patients (NCT02366377) | Jiangsu HengRui Medicine Co., Ltd. | 2015-02-01 |
| Sildenafil and Outcome of IVF/ICSI Cycles (NCT03192709) | Royan Institute | 2015-02-01 |
| A Study of Autologous Bone Marrow-Derived Mononuclear Stem Cells (BM-MNC) and Liberation Therapy (When Associated With CCSVI) in Patients With RRMS (NCT02587806) | Novo Cellular Medicine Institute LLP | 2015-02-01 |
| Subcutaneous Sterile Water Injection for Relief of Low Back Pain (NCT02813330) | Woman's Health University Hospital, Egypt | 2015-02-01 |
| A Study of Allogeneic Human UC-MSC and Liberation Therapy (When Associated With CCSVI) in Patients With RRMS (NCT02587715) | Novo Cellular Medicine Institute LLP | 2015-02-01 |
| Sperm DNA Damage in β-thalassemia Major: Is There a Role for Antioxidants? (NCT03014882) | Ain Shams University | 2015-02-01 |
| CyberKnife Stereotactic Accelerated Partial Breast Irradiation (SAPBI) (NCT02365714) | Georgetown University | 2015-02-01 |
| ESHAP-Imatinib for Refractory/Relapsed Non-Hodgkin's Lymphoma (NCT02431403) | Pusan National University Hospital | 2015-02-01 |
| Intravaginal Artesunate for the Treatment of HPV+ High Grade Cervical Intraepithelial Neoplasia (CIN2/3) (NCT02354534) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2015-02-01 |
| Study to Evaluate the Pharmacokinetic Interaction and Safety After Multiple Oral Doses of Fimasartan/Amlodipine and Rosuvastatin in Healthy Male Subjects (NCT02397538) | Boryung Pharmaceutical Co., Ltd | 2015-02-01 |
| Pilot Study of Expanded , Activated Haploidentical Natural Killer Cell Infusions for Sarcomas (NCT02409576) | National University Hospital, Singapore | 2015-02-01 |
| Phase 1 Study to Compare the Safety, Pharmacokinetic Profiles of CJ-30056 and Lipitor 20mg/Glucophage SR 750mg (NCT02378441) | HK inno.N Corporation | 2015-02-01 |
| A Study of the Effect of RG1662 on Metformin in Healthy Volunteers (NCT02342925) | Hoffmann-La Roche | 2015-02-01 |
| Effect of Oral GS-6615 on Dofetilide-Induced QT Prolongation, Safety, and Tolerability in Healthy Adults (NCT02365532) | Gilead Sciences | 2015-02-01 |
| Phase I MAD, Fed-Fasted, CSF Study of UE2343 in Healthy Subjects (NCT02616445) | Actinogen Medical | 2015-02-01 |
| Safety, Pharmacokinetics and Pharmacodynamics of NBI-77860 in Adolescent Females With Congenital Adrenal Hyperplasia (NCT02349503) | Neurocrine Biosciences | 2015-02-01 |
| Sorafenib Drug Drug Interaction Study in Healthy Male Subjects (NCT02332031) | Bayer | 2015-02-01 |
| Exploration of microRNA and Metabolomics Biomarkers Predicting Drug Induced Liver Injury in Elderly People (NCT02431832) | Seoul National University Hospital | 2015-02-01 |
| Development of Parkinson's Glove for Detection and Suppression of Hand Tremor (NCT02370134) | Chulalongkorn University | 2015-02-01 |
| A Study of BBI608 in Combination With Pemetrexed and Cisplatin in Adult Patients With Malignant Pleural Mesothelioma (NCT02347917) | Sumitomo Pharma Co., Ltd. | 2015-02-01 |
| Duvelisib With Obinutuzumab in Patients With CLL/SLL Previously Treated With a BTKi (SYNCHRONY) (NCT02292225) | SecuraBio | 2015-02-01 |
| Combination of Letrozole, Everolimus and TRC105 in Postmenopausal Women With Hormone-Receptor Positive and Her2 Negative Breast Cancer (NCT02520063) | University of Alabama at Birmingham | 2015-02-01 |
| Safety, PD & Efficacy of MT-3724 for the Treatment of Patients With Relapsed or Refractory DLBCL (NCT02361346) | Molecular Templates, Inc. | 2015-02-01 |
| Bioequivalence Study of Rivaroxaban From Repatoxaban 10 mg Tablets (Horus for Pharmaceutical Industries, Egypt) and Xarelto® 10 mg Tablets (Janssen Pharm., Licensed From: Bayer Healthcare, Germany) (NCT03071380) | Genuine Research Center, Egypt | 2015-02-01 |
| Safety, Tolerability, and Pharmacokinetics of Multiple-Dose TAK-058 in Healthy Participants (NCT02389881) | Takeda | 2015-02-01 |
| A Phase Ib Induced Malaria Infection Study With the Combination of OZ439 and DSM265 (NCT02389348) | Medicines for Malaria Venture | 2015-02-01 |
| A Study Investigating the Pharmacokinetics of FV-100 With and Without Ritonavir in Healthy Volunteers (NCT02322957) | ContraVir Pharmaceuticals, Inc. | 2015-02-01 |
| The Pharmacokinetic Drug Interaction Between Rosuvastatin and Telmisartan/Amlodipine (NCT02387619) | Jeil Pharmaceutical Co., Ltd. | 2015-02-01 |
| Safety, Tolerability, and Efficacy of MTP-131 for the Treatment of Mitochondrial Myopathy (NCT02367014) | Stealth BioTherapeutics Inc. | 2015-02-01 |